Sentence examples for serum samples were evaluated from inspiring English sources

Amperometric responses for blood serum samples were evaluated for standard deviation, whose average value was estimated to be ±0.3 nA (n = 20).

A total of 57,284 human serum samples were evaluated by anti-PA enzyme-linked immunosorbent assay (ELISA) and 11,685 samples by anthrax lethal toxin neutralization activity (TNA) assay.

All first serum samples were evaluated using the standard tests: virus isolation, RT-PCR and serology (IgM and IgG).

Neutralizing antibody responses in the pre- and post-immune serum samples were evaluated by two modified PN assays - PN entry assay and PN release/entry assay - against a panel of HA and NA pseudotypes derived from H1N1, H3N2 and H5N1 viruses.

Human serum samples were evaluated by indirect immunofluorescence assay (IFA).

During treatment, serum samples were evaluated for the presence of anti velaglucerase alfa antibodies.

The application of the immunosensor for simultaneous detection of CA125 and CA15-3 in human serum samples was evaluated and the obtained results were found to be in acceptable agreement with the those obtained with an ELISA assay as reference method.

Serological data from serum sample were evaluated using Focus Diagnostics Dengue Virus IgM and IgG Capture DxSelect™ ELISA Kits to determine IgG, IgM index values and SD Bioline Dengue Duo™ Rapid Tests to determine NS1, IgG, and IgM result.

The paired serum and SF samples were evaluated by the Wilcoxon matched pairs test.

Serum and nasal samples were evaluated by ELISA as previously described [ 38] and outlined above.

Agreement in 25OHD measurements using blood spot, serum and whole blood samples were evaluated using Bland-Altman plots, and are presented in figures 1 and 2. In the serum versus blood spot comparison of figure 1, only one point falls out the two standard deviation interval.